Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market buy Director bought 1,190,476 shares at $4.20 ($4,999,999)
  2. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  3. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  4. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  5. 4 Open-market buy Director bought 12,870,000 shares at $0.70 ($9,009,000)
  6. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  7. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  8. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  9. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  10. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  11. 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
  12. 8-K Event Material agreement · Other events
  13. 424B5 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. 8-K Event Regulation FD disclosure
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. SC 13G/A Stake Amended Statement of Ownership

Page 32 of 41 · 808 filings